VAERS reports by lot

GSK DTaP/Tdap lot T325H: VAERS reports

21 VAERS reports list lot T325H as a GSK DTaP/Tdap vaccine, received between 2015-01-19 and 2017-04-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
24%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3459%
General / Systemic (non-local)814%
Neurological47%
Cardiac / Cardiovascular47%
Allergic / Anaphylactic35%
Psychiatric / Neuropsychiatric23%
Respiratory12%
Musculoskeletal12%
Dermatological (non-injection-site)12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Utah3
Pennsylvania2
Massachusetts2
Texas1
New York1
Kentucky1
California1
Rhode Island1
Indiana1
Illinois1
Maryland1
New Jersey1

Reports by month received

2015-011
2015-021
2015-043
2015-054
2015-061
2015-073
2015-081
2015-093
2015-111
2016-051
2017-031
2017-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.